共 50 条
- [41] Effect of Weekly Carboplatin and Paclitaxel with Trastuzumab and Pertuzumab (wPCbTP) on Nodal Disease and Surgical Options in HER2-positive Breast CancerANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 2) : S421 - S422Ciambella, ChelseyDizon, DonTaneja, CharuGraves, TheresaLopresti, MarySikov, William
- [42] A phase II trial of trastuzumab plus weekly ixabepilone and carboplatin in patients with HER2-positive metastatic breast cancer: an Eastern Cooperative Oncology Group TrialBreast Cancer Research and Treatment, 2010, 119 : 663 - 671Stacy MoulderHailun LiMolin WangWilliam J. GradisharEdith A. PerezJoseph A. SparanoMichael PinsXiming YangGeorge W. Sledge
- [43] A phase II trial of trastuzumab plus weekly ixabepilone and carboplatin in patients with HER2-positive metastatic breast cancer: an Eastern Cooperative Oncology Group TrialBREAST CANCER RESEARCH AND TREATMENT, 2010, 119 (03) : 663 - 671Moulder, StacyLi, HailunWang, MolinGradishar, William J.Perez, Edith A.Sparano, Joseph A.Pins, MichaelYang, XimingSledge, George W.
- [44] WEEKLY PACLITAXEL (PCT) plus TRASTUZUMAB (T) AS FIRST-LINE THERAPY OF PATIENTS (PTS) WITH HER-2/NEU POSITIVE METASTATIC BREAST CANCER (MBC): A MULTICENTER RANDOMIZED PHASE II TRIALANNALS OF ONCOLOGY, 2004, 15 : 27 - 27Gasparini, GiampietroCrivellari, DianaFilippelli, GianfrancoMorabito, AlessandroSilingardi, VittorioDe Sio, LiviaSpada, AntonellaPapaldo, PaolaCarillio, GuidoVeronesi, A.Zancan, MateldaGion, MassimoCaputo, AntonioCognetti, FrancescoAmadori, Dino
- [45] Multicenter phase II trial of neoadjuvant carboplatin, weekly nab-paclitaxel, and trastuzumab in stage II-III HER2+breast cancer: A BrUOG studyJOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)Sinclair, Natalie FayeSakr, Bachir JosephAbu-Khalaf, Maysa M.Somlo, GeorgeBlack, Robert C.Chung, Gina G.Rizack, TinaStrenger, RochelleFenton, Mary AnneDiGiovanna, MichaelConstantinou, MariaLannin, Donald R.Legare, Robert DuffyChagpar, Anees B.Sambandam, Sundaresan T.Bossuyt, VeerieRosati, KaylaHarris, LyndsaySikov, William M.
- [46] Phase I Study of Combination Therapy With Weekly Nanoparticle Albumin-bound Paclitaxel and Cyclophosphamide in Metastatic Breast Cancer PatientsANTICANCER RESEARCH, 2019, 39 (12) : 6903 - 6907Ota, DaisukeAkatsuka, SotaroNishi, TsunehiroKato, TakaoTakeuchi, MasashiTsuji, MunechikaFukuuchi, Atsushi
- [47] Trastuzumab plus Capecitabine and Docetaxel as First-line Therapy for HER2-positive Metastatic Breast Cancer: Phase II ResultsANTICANCER RESEARCH, 2010, 30 (07) : 3051 - 3054Michalaki, VasilikiFotiou, StylianosGennatas, SpyridonGennatas, Constantine
- [48] A Phase II Trial of Oxaliplatin and Trastuzumab in the Treatment of HER2-Positive Metastatic Breast CancerCANCER INVESTIGATION, 2010, 28 (08) : 865 - 871Yardley, Denise A.Daniel, DaveyStipanov, MichaelDrosick, D. RandolphMainwaring, MarkPeyton, JamesShastry, MythiliHainsworth, John D.
- [49] Weekly paclitaxel, trastuzumab, carboplatin is a highly effective neoadjuvant regimen in HER2-positive breast cancer: Results from the TRAIN-studyCANCER RESEARCH, 2016, 76van Ramshorst, M. S.van Werkhoven, E.Mandjes, I. A. M.Schot, M.Wesseling, J.Peeters, M-JTFD VranckenRodenhuis, S.Oosterkamp, H. M.Bos, M. E. M.Terwogt, J. M. MeerumLinn, S. C.Sonke, G. S.
- [50] Neoadjuvant weekly paclitaxel and carboplatin with trastuzumab and pertuzumab in HER2-positive breast cancer: a Brown University Oncology Research Group (BrUOG) studyBREAST CANCER RESEARCH AND TREATMENT, 2021, 189 (01) : 93 - 101Lopresti, M. L.Bian, J. J.Sakr, B. J.Strenger, R. S.Legare, R. D.Fenton, M.Witherby, S. M.Dizon, D. S.Pandya, S. V.Stuckey, A. R.Edmondson, D. A.Gass, J. S.Emmick, C. M.Graves, T. A.Cutitar, M.Olszewski, A. J.Sikov, W. M.